Gulidov I A, Mardynsky Yu S, Balakin V E, Galkin V N, Gogolin D V, Kaprin A D, Lepilina O G, Ulyanenko S E, Khmelevsky E V
Vopr Onkol. 2016;62(5):570-572.
On November 23, 2015 in Protvino of the Moscow Region there was begun proton therapy using Russia's first medical therapeutic complex "Prometheus" produced by JSC "PRO- TOM" and certified to treat patients with head and neck tumors. The complex allows irradiating patients with active scanning beam. Energy of beam is 30-250MeV and maximum field size is 10 cm vertically and 40 cm horizontally. The manufacturer declared parameters were confirmed during preclinical stud- ies. By April 8, 2016 the successful proton therapy received 20 patients with complex "targets" mostly located, from the point of view of radiation tolerance, near the critical structures.
2015年11月23日，在莫斯科州的普罗特维诺，俄罗斯首台由“PRO-TOM”股份公司生产并经认证可用于治疗头颈部肿瘤患者的医疗治疗综合体“普罗米修斯”开始进行质子治疗。该综合体能够使用主动扫描束对患者进行照射。束流能量为30 - 250MeV，最大射野尺寸垂直方向为10厘米，水平方向为40厘米。制造商宣称的参数在临床前研究中得到了证实。截至2016年4月8日，已有20名患有复杂“靶点”的患者成功接受了质子治疗，从放射耐受性角度来看，这些“靶点”大多位于关键结构附近。
